Elevated HSP27, HSP70 and HSP90α in chronic obstructive pulmonary disease: Markers for immune activation and tissue destruction

Clinical Laboratory

Volumn 55, Issue 1-2, 2009, Pages 31-40

  Hacker, Stefan ^a   Lambers, Christopher ^a   Hoetzenecker, Konrad ^a   Pollreisz, Andreas ^a,b   Aigner, Clemens ^a   Lichtenauer, Michael ^a   Mangold, Andreas ^a   Niederpold, Tina ^a   Zimmermann, Matthias ^a   Taghavi, Shahrokh ^a   Klepetko, Walter ^a   Ankersmit, Hendrik Jan ^a   Hacker, S ^a   Lambers, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90ALPHA; INTERLEUKIN 6; PROTEASOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HEAT-SHOCK PROTEINS; HSP27 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LOGISTIC MODELS; PROTEASOME ENDOPEPTIDASE COMPLEX; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 63049085178     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-457.
2. Halbert RJ, Isonaka S, George D and Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123: 1684-92.
3. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121: 121S-6S.
4. Higenbottam T, Clark TJ, Shipley MJ and Rose G. Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet 1980; 1: 409-11.
5. Fairclough L, Urbanowicz RA, Corne J and Lamb JR. Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond) 2008; 114: 533-41.
6. DeMeo DL, Hersh CP, Hoffman EA et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 2007; 176: 42-8.
7. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8: 183-92.
8. Celli BR, Cote CG, Marin JM et al. The body-mass index, air-flow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12.
9. Sin DD and Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-9.
10. Ekbom A, Brandt L, Granath F, Lofdahl CG and Egesten A. Increased Risk of Both Ulcerative Colitis and Crohn's Disease in a Population Suffering from COPD. Lung 2008; 186: 167-72.
11. Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Postma DS and Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005; 26: 835-45.
12. Calderwood SK, Mambula SS, Gray PJ, Jr. and Theriault JR. Extracellular heat shock proteins in cell signaling. FEBS Lett 2007; 581: 3689-94.
13. Feder ME and Hofmann GE. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu Rev Physiol 1999; 61: 243-82.
14. Sedger L and Ruby J. Heat shock response to vaccinia virus infection. J Virol 1994; 68: 4685-9.
15. Zheng L, He M, Long M, Blomgran R and Stendahl O. Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages. J Immunol 2004; 173: 6319-26.
16. Basu S, Binder RJ, Suto R, Anderson KM and Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000; 12: 1539-46.
17. Hightower LE and Guidon PT, Jr. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J Cell Physiol 1989; 138: 257-66.
18. Asea A, Kraeft SK, Kurt-Jones EA et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000; 6: 435-42.
19. Arnold-Schild D, Hanau D, Spehner D et al. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 1999; 162: 3757-60.
20. Roth GA, Moser B, Krenn C et al. Heightened levels of circulating 20S proteasome in critically ill patients. Eur J Clin Invest 2005; 35: 399-403.
21. Hetz H, Hoetzenecker K, Hacker S et al. Caspase-cleaved cytokeratin 18 and 20 S proteasome in liver degeneration. J Clin Lab Anal 2007; 21: 277-81.
22. Szerafin T, Hoetzenecker K, Hacker S et al. Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Ann Thorac Surg 2008; 85: 80-7.
23. Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-53.
24. Mikko M, Fredriksson K, Wahlstrom J, Eriksson P, Grunewald J and Skold CM. Human T cells stimulate fibroblast-mediated degradation of extracellular matrix in vitro. Clin Exp Immunol 2008; 151: 317-25.
25. Majo J, Ghezzo H and Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001; 17: 946-53.
26. Kang MJ, Homer RJ, Gallo A et al. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol 2007; 178: 1948-59.
27. Park HK, Park EC, Bae SW et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006; 114: 886-93.
28. Djamali A, Reese S, Oberley T, Hullett D and Becker B. Heat shock protein 27 in chronic allograft nephropathy: a local stress response. Transplantation 2005; 79: 1645-57.
29. Vander Heide RS. Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2002; 282: H935-41.
30. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 2002; 22: 1547-59.
31. Madach K, Molvarec A, Rigo J et al. Elevated serum 70kDa heat shock protein level reflects tissue damage and disease severity in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Eur J Obstet Gynecol Reprod Biol 2008; 139: 133-8.
32. Vega VL, Rodriguez-Silva M, Frey T et al. Hsp70 Translocates into the Plasma Membrane after Stress and Is Released into the Extracellular Environment in a Membrane-Associated Form that Activates Macrophages. J Immunol 2008; 180: 4299-307.
33. Li W, Li Y, Guan S, Fan J et al. Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. Embo J 2007; 26: 1221-33.
34. Rajagopal D, Bal V, Mayor S, George A and Rath S. A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules. Eur J Immunol 2006; 36: 828-41.